• Zobacz wszystkie produkty ETF""

    Klasa aktywów

    Strategia

    Ważne dokumenty

  • Zapobieganie oszustwom""
    • ESG Developed Europe All Cap UCITS ETF

    ESG Developed Europe All Cap UCITS ETF - (EUR) Accumulating (V3EA)

    Available in other share classes
    Related Documents
    NAV Price ()
    —
    Market value ()
    —
    —
    Number of stocks
    —

    About this fund

    Fund objectives

    • The Fund employs a passive management – or indexing – investment approach, through physical acquisition of securities, and seeks to track the performance of the FTSE Developed Europe All Cap Choice Index (the “Index”).
    • The Fund attempts to track the performance of the Index by investing all, or substantially all, of its assets in the stocks that make up the Index in approximately the same proportion as the Index. Where not practicable to fully replicate, the Fund will use a sampling process.
    • The Index is a market-capitalisation-weighted index composed of large-, mid-, and small-cap stocks of companies located in developed markets in Europe. Market-capitalisation is the value of a company's outstanding shares in the market and shows the size of a company. The Index is constructed from the FTSE Developed Europe All Cap Index (the “Parent Index”) which is then screened for certain environmental, social, and governance (i.e. controversy-related) criteria which is independent of Vanguard.
    • Through the screening out of stocks of companies from its portfolio based on the potentially detrimental impact of their conduct or products on society and / or the environment, the Fund promotes certain environmental characteristics and social characteristics relating to social norms and standards.
    • The Index methodology excludes stocks of companies that the sponsor of the Index determines (a) to be engaged or involved in specific activities of the supply chain for, and / or (b) derive revenue (above a threshold specified by the Index provider) from, certain activities relating to the following activities: (a) Vice Products (i.e., adult entertainment, alcohol, gambling, tobacco, cannabis); (b) Non-Renewable Energy (nuclear power, and fossil fuels (which includes: (i) companies that have greater than 50% ownership of companies that own proved or probable reserves in coal, oil or gas, (ii) oil and gas production and supporting services, (iii) coal extraction, production and supporting services, (iv) oil and gas and thermal coal power generation, (v) extraction of arctic oil and gas, and (vi) extraction of oil sands)); and (c) Weapons (chemical & biological weapons, cluster munitions, anti-personnel landmines, nuclear weapons, civilian firearms, and conventional military weapons).The Index provider defines what constitutes “involvement” in each activity. This may be based on percentage of revenue or any connection to a restricted activity regardless of the amount of revenue received, and will relate to specific parts of the supply chain.
    • Company product and conduct involvement is monitored on a yearly basis by the Index provider and as new data is made available to the Index provider.
    • For the full investment strategy please review the prospectus.

    Fund facts

    Share class inception
    16 sie 2022
    Listing date
    18 sie 2022
    Investment structure
    Irish UCITS
    Share Class Assets'
    Total Assets
    Risk indicator
    Strategy
    Index
    Asset Class
    Equity
    Investment method
    Physical
    Index ticker
    FGCDEAN
    Benchmark
    FTSE Developed Europe All Cap Choice Index
    Dividend schedule
    —
    Domicile
    Ireland
    Legal entity
    Vanguard Funds PLC
    Register countries
    Bułgaria, Chorwacja, Słowenia, Węgry, Finlandia, Islandia, Malta, Norwegia, Słowacja, Hiszpania, Wyspa Man, Włochy, Luksemburg, Meksyk, Litwa, Rumunia, Szwecja, Irlandia, Cypr, Estonia, Liechtenstein, Łotwa, Francja, Grecja, Czechy, Jersey, C.I., Portugalia, Szwajcaria, Holandia, Austria, Dania, Wielka Brytania, Niemcy and Guernsey, C.I.

    The value of investments, and the income from them, may fall or rise and investors may get back less than they invested.

    Sustainability-related disclosures

    • This product promotes, among other characteristics, environmental or social characteristics, or a combination of those characteristics as specified under Article 8 of the EU SFDR.
    • Refer to the “Sustainability-related disclosures” document at the top of the webpage for the detailed disclosures in accordance with SFDR.

    Performance

    Risk and Volatility

    As at 31 lip 2026

    Beta
    R²
    Annualized Tracking Error
    1 year
    3 years
    5 years
    —

    Please note Beta and R-squared data will only display for funds with 3 full years of history.

    The value of investments, and the income from them, may fall or rise and investors may get back less than they invested.

    Portfolio data

    Characteristics
    FundamentalsFundBenchmarkAs at
    Number of stocks 966 954 31 lip 2026
    Median market capital 58,3 B 58,3 B 31 lip 2026
    16,8 x 16,9 x 31 lip 2026
    2,3 x 2,3 x 31 lip 2026
    14,1% 14,1% 31 lip 2026
    10,3% 10,3% 31 lip 2026
    Portfolio turnover rate -10,9% — 30 cze 2026

    Market allocation

    As at 31 lip 2026

    CountryRegionFundBenchmarkVariance +/-
    Wielka BrytaniaEuropa 18,55% 18,56% -0,01%
    SzwajcariaEuropa 16,70% 16,70% 0,00%
    NiemcyEuropa 14,50% 14,50% 0,00%
    HolandiaEuropa 10,38% 10,38% 0,00%
    FrancjaEuropa 9,35% 9,34% 0,01%
    SzwecjaEuropa 7,12% 7,12% 0,00%
    HiszpaniaEuropa 6,01% 6,01% 0,00%
    WłochyEuropa 5,78% 5,78% 0,00%
    DaniaEuropa 3,57% 3,57% 0,00%
    BelgiaEuropa 1,96% 1,96% 0,00%
    FinlandiaEuropa 1,87% 1,88% -0,01%
    NorwegiaEuropa 1,23% 1,23% 0,00%
    PolskaEuropa 1,14% 1,14% 0,00%
    AustriaEuropa 0,80% 0,80% 0,00%
    IrlandiaEuropa 0,80% 0,80% 0,00%

    Holdings details

    As at 31 lip 2026

    Holding name% of market valueSectorRegionMarket valueShares
    ASML Holding NV 5,57090% Technology NL 9 087 091,20 € 6336
    Roche Holding AG 2,68976% Health Care CH 4 387 462,03 € 11 550
    Novartis AG 2,55388% Health Care CH 4 165 813,60 € 30 630
    Nestle SA 2,25405% Consumer Staples CH 3 676 748,44 € 42 248
    AstraZeneca PLC 2,23062% Health Care GB 3 638 520,77 € 24 626
    Siemens AG 2,08751% Industrials DE 3 405 084,55 € 12 047
    Banco Santander SA 1,79346% Financials ES 2 925 438,77 € 237 493
    Allianz SE 1,65796% Financials DE 2 704 422,50 € 6253
    SAP SE 1,63357% Technology DE 2 664 634,32 € 16 899
    UBS Group AG 1,43863% Financials CH 2 346 654,65 € 51 337

    Total allocation percentages shown in the holdings details or the spreadsheet may not equal 100%, due to rounding or omission of cash and/or derivative instruments.

    The value of investments, and the income from them, may fall or rise and investors may get back less than they invested.

    Weighted equity exposures exclude any temporary cash investments and derivatives.

    Prices and distribution

    Prices

    NAV Price (EUR)
    7,91 €
    Change
    -0,02 €-0,23%
    At closure 17 sie 2026
    Market value (EUR)
    7,93 €
    Change
    -0,01 €-0,13%
    At closure 17 sie 2026
    NAV 52-week high
    7,96 €
    At closure 17 sie 2026
    Market value 52-week high
    7,97 €
    At closure 17 sie 2026
    NAV 52-week low
    6,51 €
    At closure 17 sie 2026
    Market value 52-week low
    6,52 €
    At closure 17 sie 2026
    NAV 52-week difference
    1,44 €
    Change
    +18,13%
    At closure 17 sie 2026
    Market value 52-week difference
    1,45 €
    Change
    +18,18%
    At closure 17 sie 2026
    Outstanding shares
    16 080 277
    At closure 31 lip 2026
    Historical Prices

    -

    Inception date

    16 sie 2022

    Listing date

    18 sie 2022

    Date NAV (EUR) Market price (EUR)
    17 sie 2026 7,9139 € 7,9280 €
    14 sie 2026 7,9324 € 7,9380 €
    13 sie 2026 7,9493 € 7,9610 €
    12 sie 2026 7,9278 € 7,9330 €
    11 sie 2026 7,9451 € 7,9650 €
    10 sie 2026 7,9505 € 7,9630 €
    07 sie 2026 7,9570 € 7,9740 €
    06 sie 2026 7,9229 € 7,9400 €
    05 sie 2026 7,9070 € 7,9140 €
    04 sie 2026 7,8929 € 7,9130 €

    Distribution history

    Distribution frequency

    —

    Historical performance

    —

    All dividends are reinvested for the "Accumulation" shares.

    The value of investments, and the income from them, may fall or rise and investors may get back less than they invested.

    Purchase information

    Currencies and stock exchanges

    Listed currencies: MXN, CHF, EUR, GBP

    Base currency: EUR

    Exchanges: Bolsa Mexicana De Valores, SIX Swiss Exchange, NYSE Euronext - Amsterdam, London Stock Exchange, Deutsche Boerse, Borsa Italiana S.p.A.

    Fund codes

    The value of investments, and the income from them, may fall or rise and investors may get back less than they invested.

    SEDOL and SEDOL Masterfile® are registered trademarks of the London Stock Exchange Group PLC. SEDOL data was extracted from the London Stock Exchange SEDOL Masterfile®.